Gang Ye, Director and Chief Operating Officer, on May 08, 2026, sold 20,000 shares in Sea (SE) for $1,704,537. Following the Form 4 filing with the SEC, Ye has control over a total of 22,536,405 shares of the company, with 22,206,405 Class A ordinary shares held directly and 330,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1703399/000119312526218080/xslF345X05/ownership.xml
Jeff L Vacirca, Director, on May 11, 2026, executed a purchase for 31,050 shares in Caris Life Sciences (CAI) for $501,426. Following the Form 4 filing with the SEC, Vacirca has control over a total of 49,671 common shares of the company, with 49,671 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2019410/000172416126000005/xslF345X05/wk-form4_1778588549.xml
Cynthia L Lucchese, Director, on May 07, 2026, executed a purchase for 125,000 shares in Mobia Medical (MOBI) for $1,875,000. Following the Form 4 filing with the SEC, Lucchese has control over a total of 125,000 common shares of the company, with 125,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1489993/000162828026033810/xslF345X05/wk-form4_1778549807.xml
William T Harrington, 10% Owner, Director, on January 30, 2026, executed a purchase for 533,333 shares in Mobia Medical (MOBI) for $7,999,995. Following the Form 4 filing with the SEC, Harrington has control over a total of 1,404,183 common shares of the company, with 1,404,183 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1489993/000162828026033811/xslF345X05/wk-form4_1778549813.xml